- Home
- GPRK vs TKNO Comparison
GPRK vs TKNO Comparison
Compare GPRK & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRK
- TKNO
- Stock Information
- Founded
- GPRK 2002
- TKNO 1996
- Country
- GPRK Colombia
- TKNO United States
- Employees
- GPRK N/A
- TKNO N/A
- Industry
- GPRK Oil & Gas Production
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- GPRK Energy
- TKNO Health Care
- Exchange
- GPRK Nasdaq
- TKNO Nasdaq
- Market Cap
- GPRK 335.7M
- TKNO 256.9M
- IPO Year
- GPRK N/A
- TKNO 2021
- Fundamental
- Price
- GPRK $6.60
- TKNO $4.35
- Analyst Decision
- GPRK Buy
- TKNO
- Analyst Count
- GPRK 1
- TKNO 0
- Target Price
- GPRK $11.00
- TKNO N/A
- AVG Volume (30 Days)
- GPRK 689.9K
- TKNO 224.0K
- Earning Date
- GPRK 08-05-2025
- TKNO 08-07-2025
- Dividend Yield
- GPRK 8.91%
- TKNO N/A
- EPS Growth
- GPRK N/A
- TKNO N/A
- EPS
- GPRK 0.81
- TKNO N/A
- Revenue
- GPRK $560,354,000.00
- TKNO $38,923,000.00
- Revenue This Year
- GPRK N/A
- TKNO $9.52
- Revenue Next Year
- GPRK N/A
- TKNO $15.20
- P/E Ratio
- GPRK $8.19
- TKNO N/A
- Revenue Growth
- GPRK N/A
- TKNO 11.40
- 52 Week Low
- GPRK $5.66
- TKNO $4.00
- 52 Week High
- GPRK $11.72
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- GPRK 50.84
- TKNO 43.35
- Support Level
- GPRK $6.28
- TKNO $4.22
- Resistance Level
- GPRK $6.67
- TKNO $4.94
- Average True Range (ATR)
- GPRK 0.20
- TKNO 0.29
- MACD
- GPRK 0.02
- TKNO -0.00
- Stochastic Oscillator
- GPRK 63.01
- TKNO 16.75
About GPRK Geopark Ltd
GeoPark Ltd is a Latin American oil and gas exploration and production company with assets in Colombia, Ecuador, Chile, Brazil, and Argentina. The company generates revenue from the sale of crude oil, condensate, and natural gas, net of value-added tax and discounts related to the sale and overriding royalties due to the ex-owners of oil and gas properties where the royalty arrangements represent a retained working interest in the property.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.